Your browser does not allow JavaScript!
JavaScript is necessary for the proper functioning of this website. Please enable JavaScript or use a modern browser.
Digital repository of Slovenian research organisations
About
Search
Browse
Statistics
Contacts
Login
Show document
A+
|
A-
|
|
SLO
|
ENG
Title:
The role of p38 MAP kinase in cancer cell apoptosis
Authors:
ID
Lenassi, Metka
(Author)
ID
Plemenitaš, Ana
(Author)
Files:
PDF - Presentation file,
download
(111,32 KB)
MD5: A6FFE72436810F3593C231688B1EF3E4
Language:
English
Typology:
1.02 - Review Article
Organization:
OI - Institute of Oncology
Abstract:
Background. Cellular behaviour in response to many extracellular stimuli is mediated through MAP kinase signalling pathways. p38 MAP kinase that is represented in mammals by four isoforms (p38alfa, p38beta, p38gama and p38delta) is one of the four main subgroups of MAP kinases. Recent studies show that p38 activation is necessary for cancer cell death initiated by variety of anti-cancer agents. This finding connected cancer therapies previously considered to be mechanistically unrelated and raised the possibility of developing anti-cancer agents that lack the side effects causedby events upstream of p38 MAPK Many of the details of p38 induced apoptosis still need to be elucidated. Since most of the past studies rely only on the cell culture models, all the results have to be verified using in vivo models. Also very little is known about the role of p38 mediated apoptosis on non-neoplastic cells in response to anti-cancer agents. Conclusion. Although p38 activation of cancer cell apoptosis is a very complexprocess, recent studies indicate a good starting point for new strategies that would increase the efficiency and decrease the toxicity of proven therapies.
Publication status:
Published
Publication version:
Version of Record
Publication date:
01.01.2006
Publisher:
Association of Radiology and Oncology
Year of publishing:
2006
Number of pages:
str. 51-56
Numbering:
Letn. 40, št. 1
Source:
Ljubljana
PID:
20.500.12556/DiRROS-18191
UDC:
616-006
ISSN on article:
1318-2099
COBISS.SI-ID:
21116889
Copyright:
by Authors
Note:
BSDOCID122314;
Publication date in DiRROS:
15.02.2024
Views:
490
Downloads:
101
Metadata:
Cite this work
Plain text
BibTeX
EndNote XML
EndNote/Refer
RIS
ABNT
ACM Ref
AMA
APA
Chicago 17th Author-Date
Harvard
IEEE
ISO 690
MLA
Vancouver
:
Copy citation
Share:
Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.
Record is a part of a journal
Title:
Radiology and oncology
Shortened title:
Radiol. oncol.
Publisher:
Slovenian Medical Society - Section of Radiology, Croatian Medical Association - Croatian Society of Radiology
ISSN:
1318-2099
COBISS.SI-ID:
32649472
Secondary language
Language:
Slovenian
Title:
[Vloga p38 MAP kinaze pri apoptozi rakavih celic]
Abstract:
Izhodišča. Odzivanje celic na številne zunajcelične signale poteka preko aktivacije MAP kinaznih signalnih poti. Ena od štirih glavnih podskupin MAP kinaz je p38 MAP kinaza, ki je pri sesalcih prisotna v štirih izooblikah: p38alfa, p38beta, p38gama in p38delta. Nedavne raziskave so pokazale, da je zaaktivacijo apoptoze rakavih celic z različnimi kemoterapevtiki nujna aktivacija p38 kinaze. To spoznanje je v eni točki povezalo poti delovanja raznolikih kemoterapevtikov ter s tem nakazalo nove možnosti njihovega razvojabrez stranskih učinkov, ki jih sedaj povzročajo dogodki pred aktivacijop38. Veliko podrobnosti o p38 posredovani apoptozi je potrebno še razjasniti. Dosedanja dognanja je potrebno preveriti v in vivo modelih, saj seta sedaj nanašajo predvsem na celične kulture. Malo je znanega tudi o vlogi p38 pri apoptozi nerakavih celic po aktivaciji s kemoterapevtiki. Zaključki. Čeprav je p38 posredovana aktivacija apoptoze rakavih celic zelo kompleksen proces, novejše študije ponujajo dober začetek za razvoj novih kemoterapevtikov s povečano učinkovitostjo in zmanjšano toksičnostjo.
Back